-
21por Koganti, Raghuram, Yadavalli, Tejabhiram, Sutar, Yogesh, Mallick, Sudipta, Date, Abhijit, Shukla, Deepak“…Topical corticosteroids are the common treatments for corneal inflammation, but the drugs cause serious and potentially blinding side effects in the long term. Therefore, new standalone and/or synergistic anti-inflammatory therapies with lower side effects are desperately needed. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
22por Mallone, Fabiana, Costi, Roberta, Marenco, Marco, Plateroti, Rocco, Minni, Antonio, Attanasio, Giuseppe, Artico, Marco, Lambiase, Alessandro“…To date, the only available treatments are antimetabolite drugs that have significant potentially blinding side effects, such as tissue damage and infection. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
23por Kozdon, Katarzyna, Caridi, Bruna, Duru, Iheukwumere, Ezra, Daniel G., Phillips, James B., Bailly, Maryse“…Currently used antimetabolite treatments to prevent post-surgical scarring are non-selective and are associated with potentially blinding side effects. Developing new treatments to target scarring requires both a better understanding of wound healing and scarring in the conjunctiva, and new means of delivering anti-scarring drugs locally and sustainably. …”
Publicado 2020
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
24por Gruca, Thomas S., Hottel, Wesley J., Comstock, Janine, Olson, Anna, Rosenthal, Gary E.“…There were no significant differences based on sex or CVD status for attitudes on randomization, blinding, side effects, conflict of interest, experimental treatments or willingness to talk to one’s physician. …”
Publicado 2018
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
25por Cano, Guillermo, Cavalcanti, Marcia Oliveira, Orveillon, Francois-Xavier, Kroll, Jeremy, Gomez-Duran, Oliver, Morillo, Alberto, Kraft, Christian“…The efficacy of a novel PRRS modified live vaccine (Ingelvac PRRSFLEX® EU) was studied in a blinded, side-by-side placebo controlled field study of piglet vaccination including piglets weaned for three consecutive weeks (week groups 1, 2 and 3). …”
Publicado 2016
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto